Carmine N. Stengone

Carmine N. Stengone does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KIORA PHARMACEUTICALS INC, and Contineum Therapeutics, Inc..

2026 was Carmine N. Stengone's most active year for acquiring shares with 4 total transactions. Carmine N. Stengone's most active month to acquire stocks was the month of January. 2026 was Carmine N. Stengone's most active year for disposing of shares, totalling 6 transactions. Carmine N. Stengone's most active month to dispose stocks was the month of January. 2026 saw Carmine N. Stengone paying a total of $9,450.00 for 452,500 shares, this is the most they've acquired in one year. In 2026 Carmine N. Stengone cashed out on 15,000 shares for a total of $120,127.65, their largest year based on trade value.